UBS (UBS) warns Swiss capital proposal may add $23B CET1 burden

UBS has formally opposed a Swiss Federal Council proposal that would fully deduct foreign subsidiaries from CET1, estimating the measure would require about USD 23 billion of additional CET1 (raising total post‑Credit Suisse and regulatory add‑ons to ~USD 39 billion) and add roughly USD 1.7 billion in annual capital costs. The bank warns the change would harm competitiveness, force higher client prices, and has coincided with roughly 27% share underperformance versus European and US peers (≈CHF 30 billion lost market value); UBS proposes alternatives such as partial deductions, higher risk weights, or greater use of bail‑in instruments.

Analysis

Market structure: The Swiss proposal is a direct negative for UBS (UBS) — UBS’s estimate of ~USD 23bn extra CET1 (and ~USD 1.7bn p.a. in capital cost) implies immediate equity and credit weakness; the stock has already lagged peers by ~27% (~CHF30bn). Winners are non‑Swiss global banks (e.g., BNP.PA, HSBA.L) and capital‑light wealth managers who avoid a full deduction; Swiss corporates and domestic lenders face tighter credit pricing. Cross‑asset: expect UBS equity down, 5y CDS wider, AT1 prices depressed, and modest CHF weakness if capital flight risk rises.

Risk assessment: Tail risks include a hardline Swiss law forcing an equity raise >USD20bn (high dilution), rating downgrades and forced asset disposals — low probability but >10% idiosyncratic shock with severe downside. Timeline: days = equity/CDS volatility; weeks–months = regulatory votes and potential capital actions; quarters–years = structural shift of international business out of Switzerland. Hidden dependencies: Credit Suisse integration costs (~USD14bn) magnify capital strain; EU/UK rule divergence creates regulatory arbitrage and client migration. Key catalysts: Federal Council/parliament votes (next 1–6 months) and rating‑agency reviews.

Trade implications: Tactical plays favor underweight UBS and overweight resilient EU/UK banks. Implement a 3–6m asymmetric short: buy 3–6m 25% OTM put spreads on UBS equal to ~2% portfolio risk or short 2% notional stock with a 15% stop; buy 5y CDS protection sized to cover 1% portfolio value for 6–12m. Pair trade: long BNP.PA 2% / short UBS 2% for 3–6m to capture regulatory arbitrage. Rotate 2–4% of bank exposure from Swiss banks into BNP.PA and HSBA.L.

Contrarian angles: The market may overprice a permanent 100% deduction — probability of a moderated outcome (partial deduction, 250% RW or exemptions) is material and would trigger a rapid recovery (30–50% upside from trough). Historical parallel: regulatory shock sell‑offs (post‑2008/2012) reversed within 6–12 months after policy adjustments. Position with option convexity (puts and put spreads) and modest size to capture asymmetric payoff if Switzerland softens rules.

Key Decisions for Investors

• Establish a tactical 2% notional short-equity exposure to UBS (UBS) via 3–6 month 25% OTM put spreads (limits premium outlay), target exit on a 25% further downside or reduction in Swiss draft to partial deduction; stop-loss +15% premium move.
• Buy 5-year CDS protection on UBS sized to hedge 1% of portfolio value (horizon 6–12 months); unwind if CDS tightens >100bps or Swiss publishes a mitigated draft within 60 days.
• Implement a pair trade: long BNP Paribas (BNP.PA) 2% of portfolio vs short UBS 2% for 3–6 months to capture relative regulatory arbitrage; rebalance if relative performance gap narrows >15%.
• Reduce Swiss-bank weight to <2% of financials allocation and redeploy 2–4% into EU/UK large-cap banks (BNP.PA, HSBA.L) over the next 30 days; reassess post-parliamentary vote or rating agency action within 3 months.